![Mark Timney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Timney
Vorstandsvorsitzender bei
Attralus, Inc.
Profil
Derzeit ist Mark Timney Chairman bei Blade Therapeutics, Inc. und Chief Executive Officer & Director bei The Medicines Co. Herr Timney ist auch im Vorstand der Biotechnology Innovation Organization, Pharmaceutical Research & Manufacturers of America und Sarissa Capital Acquisition Corp. In seiner früheren Laufbahn war Mark Timney President & Chief Executive Officer bei Purdue Pharma LP, President-Global Primary Care bei Merck & Co, Inc. und Chief Executive Officer & Director bei The Medicines Co. Mark Timney erwarb einen Bachelor-Abschluss an der University of Northumbria.
Aktive Positionen von Mark Timney
| Unternehmen | Position | Beginn |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | - |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Vorsitzender | 01.08.2020 |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Vorstandsvorsitzender | 10.05.2021 |
Anfield Road LLC | Vorstandsvorsitzender | 01.01.2017 |
Ehemalige bekannte Positionen von Mark Timney
| Unternehmen | Position | Ende |
|---|---|---|
| SARISSA CAPITAL ACQUISITION CORP. | Direktor/Vorstandsmitglied | 13.04.2023 |
| THE MEDICINES COMPANY | Vorstandsvorsitzender | 01.01.2020 |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Vorstandsvorsitzender | 23.06.2017 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.07.2014 |
Ausbildung von Mark Timney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
University of Northumbria
 University of Northumbria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
Sarissa Capital Acquisition Corp.
 Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Anfield Road LLC |
Wählen Sie MarketScreener 
